N-(2-aminoethyl)-3-(3,5-dimethylphenyl)-5-(5-hydroxynaphthalen-2-yl)isonicotinamide

ID: ALA5279978

Chembl Id: CHEMBL5279978

Max Phase: Preclinical

Molecular Formula: C26H25N3O2

Molecular Weight: 411.51

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C)cc(-c2cncc(-c3ccc4c(O)cccc4c3)c2C(=O)NCCN)c1

Standard InChI:  InChI=1S/C26H25N3O2/c1-16-10-17(2)12-20(11-16)23-15-28-14-22(25(23)26(31)29-9-8-27)19-6-7-21-18(13-19)4-3-5-24(21)30/h3-7,10-15,30H,8-9,27H2,1-2H3,(H,29,31)

Standard InChI Key:  DLQDTOXPYMCBJT-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5279978

    ---

Associated Targets(Human)

SSTR2 Tclin Somatostatin receptor 2 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR4 Tclin Somatostatin receptor 4 (1125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.51Molecular Weight (Monoisotopic): 411.1947AlogP: 4.58#Rotatable Bonds: 5
Polar Surface Area: 88.24Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.70CX Basic pKa: 9.01CX LogP: 3.56CX LogD: 2.31
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.45Np Likeness Score: -0.18

References

1. Zhao J, Wang S, Markison S, Kim SH, Han S, Chen M, Kusnetzow AK, Rico-Bautista E, Johns M, Luo R, Struthers RS, Madan A, Zhu Y, Betz SF..  (2023)  Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist.,  14  (1.0): [PMID:36655128] [10.1021/acsmedchemlett.2c00431]

Source